Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Sarcoma × plerixafor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Leukemia, Lymphocytic, Chronic, B-Cell 4 Myelodysplastic Syndromes 3 Sezary Syndrome 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Hairy Cell 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Sarcoma, Myeloid 1 Sarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1

Interventions

Doxorubicin 11 Cyclophosphamide 9 Gemcitabine 8 Filgrastim 7 Cisplatin 7 pazopanib 6 Docetaxel 6 Irinotecan 5 Ifosfamide 5 Etoposide 5 Trabectedin 4 Radiotherapy 4 Radiation 4 Magnetic Resonance Spectroscopy 4 Granulocyte Colony-Stimulating Factor 4 Celecoxib 4 Busulfan 4 sargramostim 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Neoadjuvant Therapy 3 Cryosurgery 3 temsirolimus 2 pembrolizumab 2 ixabepilone 2 ganitumab 2 fluoromisonidazole 2 Thiotepa 2 TTI-621 2 Sirolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03240861 2023-11-01

NYESO SCT

Jonsson Comprehensive Cancer Center

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡